Mirum Pharmaceuticals to release Phase 3 hepatitis delta trial data
Tweet Send to a Friend
Mirum Pharmaceuticals (NASDAQ: MIRM) announced it will host an investor call on September 28, 2026, to share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


